Citation 1:
    Title: Johnson & Johnson - 63 Year Stock Price History | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/stock-price-history#:~:text=%2A%20The%20all,below%20the%20current%20share%20price
    Location: chars 424–592

Citation 2:
    Title: J&J shares fall after judge rejects $10 billion talc settlement
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-shares-fall-after-judge-rejects-10-billion-talc-settlement-2025-04-01/#:~:text=purpose,capitalization%20of%20roughly%20%24400%20billion
    Location: chars 613–832

Citation 3:
    Title: Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2% | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-Announces-62nd-Consecutive-Year-of-Dividend-Increase-Raises-Quarterly-Dividend-by-4.2/#:~:text=At%20the%20new%20rate%2C%20the,the%20close%20of%20business%20on
    Location: chars 856–1109

Citation 4:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=match%20at%20L101%20On%20February,shares%20of%20Common%20Stock%20outstanding
    Location: chars 1138–1322

Citation 5:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%20Company%20issues%20guidance%20for,point
    Location: chars 1441–1624

Citation 6:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=billion,the%20end%20of%202024%20was
    Location: chars 1712–1855

Citation 7:
    Title: J&J earnings beat estimates on strong cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-wall-street-quarterly-sales-profit-estimates-cancer-drug-sales-2025-04-15/#:~:text=healthcare%20giant%20reported%20adjusted%20earnings,acquisition%20of%20schizophrenia%20drug%20Caplyta
    Location: chars 2074–2348

Citation 8:
    Title: J&J earnings beat estimates on strong cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-wall-street-quarterly-sales-profit-estimates-cancer-drug-sales-2025-04-15/#:~:text=About%20%24400%20million%20in%20tariff,due%20to
    Location: chars 2438–2658

Citation 9:
    Title: J&J earnings beat estimates on strong cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-wall-street-quarterly-sales-profit-estimates-cancer-drug-sales-2025-04-15/#:~:text=Johnson%20%26%20Johnson%20,4
    Location: chars 2687–2888

Citation 10:
    Title: J&J earnings beat estimates on strong cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-wall-street-quarterly-sales-profit-estimates-cancer-drug-sales-2025-04-15/#:~:text=2025%20earnings%2C%20driven%20by%20strong,4
    Location: chars 2937–3153

Citation 11:
    Title: J&J earnings beat estimates on strong cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-wall-street-quarterly-sales-profit-estimates-cancer-drug-sales-2025-04-15/#:~:text=estimates%20by%2018%20cents%2C%20and,Cellular%2C%20although%20it%20maintained%20its
    Location: chars 3372–3628

Citation 12:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%20Company%20issues%20guidance%20for,point
    Location: chars 3667–3850

Citation 13:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%20Company%20issues%20guidance%20for,point
    Location: chars 3894–4077

Citation 14:
    Title: Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China
    URL: https://apnews.com/article/103d0074599788cf6f3ceee93269c3d2#:~:text=Johnson%20%26%20Johnson%20anticipates%20incurring,Importantly%2C%20the%20estimate
    Location: chars 4164–4329

Citation 15:
    Title: Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China
    URL: https://apnews.com/article/103d0074599788cf6f3ceee93269c3d2#:~:text=excludes%20possible%20tariffs%20on%20pharmaceutical,occurs%20domestically
    Location: chars 4402–4559

Citation 16:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%20Significant%20pipeline%20progress%20including,
    Location: chars 4657–4847

Citation 17:
    Title: J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
    URL: https://apnews.com/article/19160ba4559aaab40836078d12a89800#:~:text=Johnson%20%26%20Johnson%20is%20investing,Cellular
    Location: chars 4992–5125

Citation 18:
    Title: Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2% | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-Announces-62nd-Consecutive-Year-of-Dividend-Increase-Raises-Quarterly-Dividend-by-4.2/#:~:text=At%20the%20new%20rate%2C%20the,the%20close%20of%20business%20on
    Location: chars 5226–5479

Citation 19:
    Title: Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2% | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-Announces-62nd-Consecutive-Year-of-Dividend-Increase-Raises-Quarterly-Dividend-by-4.2/#:~:text=announced%20that%20its%20Board%20of,nd%7D%20year%20of%20consecutive%20increases
    Location: chars 5607–5876

Citation 20:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=match%20at%20L1845%20,of%20the%20Company%E2%80%99s%20compensation%20programs
    Location: chars 5950–6134

Citation 21:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%20Significant%20pipeline%20progress%20including,
    Location: chars 7137–7327

Citation 22:
    Title: J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
    URL: https://apnews.com/article/19160ba4559aaab40836078d12a89800#:~:text=Johnson%20%26%20Johnson%20is%20investing,Cellular
    Location: chars 7404–7537

Citation 23:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%20Company%20issues%20guidance%20for,point
    Location: chars 7934–8117

Citation 24:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%202024%20Fourth,98
    Location: chars 8437–8597

Citation 25:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%242,98
    Location: chars 8675–8814

Citation 26:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=excluding%20COVID,various%20transactions%20throughout%20the%20year
    Location: chars 8848–9046

Citation 27:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%20Company%20issues%20guidance%20for,point
    Location: chars 9156–9339

Citation 28:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%20Significant%20pipeline%20progress%20including,
    Location: chars 9628–9818

Citation 29:
    Title: J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
    URL: https://apnews.com/article/19160ba4559aaab40836078d12a89800#:~:text=Johnson%20%26%20Johnson%20is%20investing,Cellular
    Location: chars 9922–10055

Citation 30:
    Title: J&J to exit spinoff Kenvue with latest stake sale
    URL: https://www.reuters.com/markets/deals/jj-sell-all-shares-spun-off-unit-kenvue-2024-05-13/#:~:text=Johnson%20%26%20Johnson%20,its%20pharmaceutical%20and%20medical%20devices
    Location: chars 10124–10316

Citation 31:
    Title: Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China
    URL: https://apnews.com/article/103d0074599788cf6f3ceee93269c3d2#:~:text=Johnson%20%26%20Johnson%20anticipates%20incurring,Importantly%2C%20the%20estimate
    Location: chars 10433–10598

Citation 32:
    Title: Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China
    URL: https://apnews.com/article/103d0074599788cf6f3ceee93269c3d2#:~:text=excludes%20possible%20tariffs%20on%20pharmaceutical,occurs%20domestically
    Location: chars 10698–10855

Citation 33:
    Title: Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025 | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2025/Johnson--Johnson-Announces-Quarterly-Dividend-for-First-Quarter-2025/default.aspx#:~:text=NEW%20BRUNSWICK%2C%20N.J.,date%20is%20February%2018%2C%202025
    Location: chars 11014–11243

Citation 34:
    Title: Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2% | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-Announces-62nd-Consecutive-Year-of-Dividend-Increase-Raises-Quarterly-Dividend-by-4.2/#:~:text=At%20the%20new%20rate%2C%20the,the%20close%20of%20business%20on
    Location: chars 11304–11557

Citation 35:
    Title: J&J shares fall after judge rejects $10 billion talc settlement
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-shares-fall-after-judge-rejects-10-billion-talc-settlement-2025-04-01/#:~:text=Johnson%20%26%20Johnson%27s%20shares%20fell,traditional%20legal%20system%20to%20fight
    Location: chars 11654–11902

Citation 36:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%202024%20Full,98
    Location: chars 12245–12403

Citation 37:
    Title: J&J earnings beat estimates on strong cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-wall-street-quarterly-sales-profit-estimates-cancer-drug-sales-2025-04-15/#:~:text=2025%20earnings%2C%20driven%20by%20strong,4
    Location: chars 12487–12703

Citation 38:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%20Company%20issues%20guidance%20for,point
    Location: chars 13042–13225

Citation 39:
    Title: J&J earnings beat estimates on strong cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-wall-street-quarterly-sales-profit-estimates-cancer-drug-sales-2025-04-15/#:~:text=Johnson%20%26%20Johnson%20,4
    Location: chars 13439–13640

Citation 40:
    Title: Johnson & Johnson Market Cap 2010-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/market-cap#:~:text=Eli%20Lilly%20,13.06
    Location: chars 14191–14317

Citation 41:
    Title: Johnson & Johnson Market Cap 2010-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/market-cap#:~:text=Eli%20Lilly%20,13.06
    Location: chars 14342–14468

Citation 42:
    Title: Johnson & Johnson Market Cap 2010-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/market-cap#:~:text=Eli%20Lilly%20,13.06
    Location: chars 14512–14638

Citation 43:
    Title: Johnson & Johnson Market Cap 2010-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/market-cap#:~:text=Eli%20Lilly%20,13.06
    Location: chars 14663–14789

Citation 44:
    Title: Johnson & Johnson Market Cap 2010-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/market-cap#:~:text=Eli%20Lilly%20,13.06
    Location: chars 14834–14960

Citation 45:
    Title: Johnson & Johnson Market Cap 2010-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/market-cap#:~:text=Novo%20Nordisk%20,13.06
    Location: chars 14985–15114

Citation 46:
    Title: Johnson & Johnson Market Cap 2010-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/market-cap#:~:text=Roche%20Holding%20AG%20,10.18
    Location: chars 15158–15293

Citation 47:
    Title: Johnson & Johnson Market Cap 2010-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/market-cap#:~:text=AbbVie%20%28ABBV%29%20%20%20,10.18
    Location: chars 15318–15458

Citation 48:
    Title: Johnson & Johnson Market Cap 2010-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/market-cap#:~:text=Merck%20%28MRK%29%20%20%20,6.38
    Location: chars 15503–15640

Citation 49:
    Title: Johnson & Johnson Market Cap 2010-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/market-cap#:~:text=Merck%20%28MRK%29%20%20%20,6.38
    Location: chars 15665–15802

Citation 50:
    Title: Johnson & Johnson Market Cap 2010-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/market-cap#:~:text=Eli%20Lilly%20,13.06
    Location: chars 15893–16019

Citation 51:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=billion,the%20end%20of%202024%20was
    Location: chars 16595–16738

Citation 52:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=The%20Company%20has%20access%20to,of%20funds%20at%20numerous%20banks
    Location: chars 16785–16961

Citation 53:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=Cash%20flow%20from%20operations%20of,3%C2%A0billion%20was%20the%20result%20of
    Location: chars 17112–17297

Citation 54:
    Title: Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2% | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-Announces-62nd-Consecutive-Year-of-Dividend-Increase-Raises-Quarterly-Dividend-by-4.2/#:~:text=announced%20that%20its%20Board%20of,nd%7D%20year%20of%20consecutive%20increases
    Location: chars 17505–17774

Citation 55:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=Net%20earnings%20%20,2%2C389
    Location: chars 17912–18048

Citation 56:
    Title: Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China
    URL: https://apnews.com/article/103d0074599788cf6f3ceee93269c3d2#:~:text=Johnson%20%26%20Johnson%20anticipates%20incurring,Importantly%2C%20the%20estimate
    Location: chars 18491–18656

Citation 57:
    Title: J&J shares fall after judge rejects $10 billion talc settlement
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-shares-fall-after-judge-rejects-10-billion-talc-settlement-2025-04-01/#:~:text=Johnson%20%26%20Johnson%27s%20shares%20fell,traditional%20legal%20system%20to%20fight
    Location: chars 18747–18995

Citation 58:
    Title: J&J earnings beat estimates on strong cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-wall-street-quarterly-sales-profit-estimates-cancer-drug-sales-2025-04-15/#:~:text=device%20segment%2C%20reflecting%20current%20U,due%20to
    Location: chars 19092–19320

Citation 59:
    Title: J&J to exit spinoff Kenvue with latest stake sale
    URL: https://www.reuters.com/markets/deals/jj-sell-all-shares-spun-off-unit-kenvue-2024-05-13/#:~:text=Johnson%20%26%20Johnson%20,its%20pharmaceutical%20and%20medical%20devices
    Location: chars 19692–19884

Citation 60:
    Title: J&J to exit spinoff Kenvue with latest stake sale
    URL: https://www.reuters.com/markets/deals/jj-sell-all-shares-spun-off-unit-kenvue-2024-05-13/#:~:text=Johnson%20%26%20Johnson%20,its%20pharmaceutical%20and%20medical%20devices
    Location: chars 20314–20506

Citation 61:
    Title: Johnson & Johnson Market Cap 2010-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/market-cap#:~:text=Eli%20Lilly%20,13.06
    Location: chars 20866–20992

Citation 62:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%20Company%20issues%20guidance%20for,point
    Location: chars 21216–21399

Citation 63:
    Title: J&J earnings beat estimates on strong cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-wall-street-quarterly-sales-profit-estimates-cancer-drug-sales-2025-04-15/#:~:text=Johnson%20%26%20Johnson%20,4
    Location: chars 23168–23369

Citation 64:
    Title: J&J earnings beat estimates on strong cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-wall-street-quarterly-sales-profit-estimates-cancer-drug-sales-2025-04-15/#:~:text=About%20%24400%20million%20in%20tariff,due%20to
    Location: chars 23370–23590

Citation 65:
    Title: J&J to exit spinoff Kenvue with latest stake sale
    URL: https://www.reuters.com/markets/deals/jj-sell-all-shares-spun-off-unit-kenvue-2024-05-13/#:~:text=Johnson%20%26%20Johnson%20,its%20pharmaceutical%20and%20medical%20devices
    Location: chars 23706–23898

Citation 66:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%202024%20Fourth,98
    Location: chars 24056–24216

Citation 67:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=%E2%80%A2%20Significant%20pipeline%20progress%20including,point
    Location: chars 24217–24412

Citation 68:
    Title: Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript | Seeking Alpha
    URL: https://seekingalpha.com/article/4751206-johnson-and-johnson-jnj-q4-2024-earnings-call-transcript#:~:text=,Y%2FY%29%20beats%20by%20%2484.41M
    Location: chars 24539–24701

Citation 69:
    Title: Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024 | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-Announces-Quarterly-Dividend-for-Fourth-Quarter-2024/default.aspx#:~:text=NEW%20BRUNSWICK%2C%20N.J.,date%20is%20November%2026%2C%202024
    Location: chars 24879–25109

Citation 70:
    Title: Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025 | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2025/Johnson--Johnson-Announces-Quarterly-Dividend-for-First-Quarter-2025/default.aspx#:~:text=NEW%20BRUNSWICK%2C%20N.J.,date%20is%20February%2018%2C%202025
    Location: chars 25265–25494

Citation 71:
    Title: Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2% | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-Announces-62nd-Consecutive-Year-of-Dividend-Increase-Raises-Quarterly-Dividend-by-4.2/#:~:text=announced%20that%20its%20Board%20of,nd%7D%20year%20of%20consecutive%20increases
    Location: chars 25676–25945

Citation 72:
    Title: J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
    URL: https://apnews.com/article/19160ba4559aaab40836078d12a89800#:~:text=Johnson%20%26%20Johnson%20is%20investing,Cellular
    Location: chars 26119–26252

Citation 73:
    Title: J&J shares fall after judge rejects $10 billion talc settlement
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-shares-fall-after-judge-rejects-10-billion-talc-settlement-2025-04-01/#:~:text=Johnson%20%26%20Johnson%27s%20shares%20fell,traditional%20legal%20system%20to%20fight
    Location: chars 26376–26624

Citation 74:
    Title: Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China
    URL: https://apnews.com/article/103d0074599788cf6f3ceee93269c3d2#:~:text=Johnson%20%26%20Johnson%20anticipates%20incurring,Importantly%2C%20the%20estimate
    Location: chars 26780–26945

Citation 75:
    Title: Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China
    URL: https://apnews.com/article/103d0074599788cf6f3ceee93269c3d2#:~:text=excludes%20possible%20tariffs%20on%20pharmaceutical,occurs%20domestically
    Location: chars 26946–27103

Citation 76:
    Title: Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-increases-u-s-investment-to-more-than-55-billion-over-the-next-four-years#:~:text=supporting%20American%20jobs%20Includes%20four,more%20than%20%24100%20billion%20per
    Location: chars 27275–27521

Citation 77:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=billion,the%20end%20of%202024%20was
    Location: chars 27644–27787

Citation 78:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=The%20Company%20has%20access%20to,of%20funds%20at%20numerous%20banks
    Location: chars 27788–27964

Citation 79:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=match%20at%20L101%20On%20February,shares%20of%20Common%20Stock%20outstanding
    Location: chars 27965–28149

Citation 80:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=match%20at%20L1845%20,of%20the%20Company%E2%80%99s%20compensation%20programs
    Location: chars 28241–28425

Citation 81:
    Title: Johnson & Johnson Market Cap 2010-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/market-cap#:~:text=Eli%20Lilly%20,13.06
    Location: chars 28535–28661

